17 jul: Test
24 jul: Bobler fra dybet fik hammerslag på rekordpriser ved nyligt afhold..
18-07-2012 09:17:00

UPDATE: Ericsson Earnings Miss Views as Poor Margins Weigh

Relateret indhold
Relateret debat
13 feb - 
@OTHolding Hvad siger du til Ericsson her i februar 201..

--Ericsson disappoints with bigger than expected drop in net profit

--Earnings hit by low-margin contracts and weak demand in Europe, China

--U.S. sales remains strong

(Adds detail, analyst comment.)

By Gustav Sandstrom and Sven Grundberg

STOCKHOLM--Swedish network equipment vendor Ericsson (ERIC) Wednesday reported a bigger-than-expected drop in second-quarter earnings with profits stunted by a high number of low-margin sales in Europe and slow demand in some markets, but said it expects improvement towards the end of the year.

Ericsson's net profit fell 64% to 1.11 billion Swedish kronor ($159 million) from SEK3.12 billion in the same quarter last year, with the closely watched gross margin down to 32.0% from 37.8% a year ago. Analysts polled by Dow Jones Newswires had expected net profit of SEK1.67 billion and a gross margin of 33.3%.

The weak numbers mirror problems cited by French peer Alcatel-Lucent SA (ALU.FR) Tuesday, which said it will miss its forecasts this year due to thin margins on big contracts and sluggish demand in Europe.

Ericsson has managed to maintain its position as the world's biggest network equipment vendor throughout the global financial crisis, helped by its strong position in the fast-growing U.S. market. Still, the company's profits have been hit in past months by a high proportion of low-margin sales, and as a result of reluctance by telecom operators in Europe to invest in new gear amid the ongoing financial crisis.

Revenue from services, which typically have lower margins than sales of new network equipment, made up a larger part of Ericsson's sales mix in the second quarter. Profit also suffered as a result of a large number of low-margin contracts for network upgrades in Europe, that Ericsson has taken on to regain market share in the region.

"The negative gross margin impact from the network modernization projects in Europe will start to gradually decline end 2012," the company said in a statement

Net sales in the quarter were down to SEK55.32 billion from SEK54.77 billion the same quarter last year, against expectations for SEK54.5 billion.

Ericsson's global services and support solutions businesses saw strong demand, but networks sales fell from a year earlier, mainly due to slow sales of CDMA technology equipment, lower activity in China, and slow third-generation (3G) technology sales in Russia, the company said.

Ericsson repeated that operators in Europe have turned increasingly cautious, as a result of the deteriorating economic situation in the region. Sales in Western and Central Europe tumbled 6% in the quarter compared with a year earlier.

North America remained strong, however. Sales climbed 5% year-on-year and the region remained a bright spot as carriers such as AT&T (T), Sprint Nextel Corp. (S), Verizon Wireless and Deutsche Telecom AG's (DTE.XE) T-Mobile USA invest heavily in increasing third-generation wireless data capacity and building fourth-generation Long Term Evolution networks.

The investments in 4G capability in the U.S. is largely due to the rapid pick-up of phones and tablet PCs enabled with high speed wireless data functionality, such as Apple Inc.'s (AAPL) new iPad that the company launched in March this year.

Ericsson's shares are down around 16% so far this year, underperforming a 3.7% rise in the wider Stockholm market amid concerns that its closely-watched gross margin will remain subdued. The shares Tuesday closed at 58.90.

Write to Gustav Sandstrom at gustav.sandstrom@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 18, 2012 03:17 ET (07:17 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
17 feb
AAPL
Prøv lige at læse din egen trådstart igen: “Kina har netop meddelt at apple ikke må producere i land..
8
17 feb
AAPL
Helt enig, men taastrup har en dårlig vane, med at slynge om sig med udokumenterbare påstande.
4
18 feb
AAPL
Taastrup  -  alle ved sgu da hvad en handelskrig er.   Og alle ved du er fuld af løgn når du siger d..
3
17 feb
AAPL
Taastrup, Jeg hæfter mig ved, at du nu i dette indlæg formulerer dig i fremtidsform. Kina har altså ..
3
17 feb
AAPL
Taastrup, Det må du simpelthen kunne gøre bedre. Du må i sagens natur have oplysningen et sted fra. ..
3
18 feb
AAPL
http://onx.dk/nyheder/iphone-x-er-verdens-mest-solgte-smartphone-i-oejeblikket/
2
18 feb
AAPL
Under World Economic Forum i januar roste milliardæren George Soros den danske EU-konkurrencekommiss..
2
17 feb
AAPL
så må vi have margrethe vestager ind over...det er da for galt? stavnsbinding  af ytringsfriheden må..
2
17 feb
AAPL
Taasturp - nu ved jeg ikke hvad kun jeg ved (som du skriver) - Men jeg VED at der ikke står noget om..
2
17 feb
AAPL
Fake news!
2

Fondsbørsmeddelelser

Aktier/middag: Genmab buldrer frem med WDH og ISS som følgesvende

22-02-2018 11:40:57
Biotekselskabet Genmab ligger helt i top i det danske eliteindeks torsdag middag efter at have præsenteret regnskab onsdag aften. Også ISS og William Demant, der begge kom med regnskab for fjerde kvartal torsdag morgen, er med i toppen.Men det er onsdagens regnskab fra Genmab, der trækker den helt store opmærksomhed, efter at biotekselskabet gjorde markedets bekymringer over en mulig skuffende pro..

ISS: Salget vokser mens bundlinjen skrumper

22-02-2018 08:39:00
ISS kan se bundlinjen falde tilbage i 2017 sammenlignet med i 2016, selvom selskabet er vokset på salget.Omsætningen i selskabet voksede til 79.912 mio. kr. i 2017, mens omsætningen udgjorde 78.658 mio. kr. i 2016.Omvendt steg nettoresultatet i 2017 til 2007 mio. kr. mod 2220 mio. kr. året før.Af regnskabet fremgår det, at årsagen til at bundlinjen ikke vokser med toplinjen, blandt andet er ekster..

Novo Nordisk: Ozempic optaget på stor indkøbsforenings tilskudsliste

21-02-2018 15:39:04
Novo Nordisks nylancerede ugentlige GLP-1-analog Ozempic er blevet optaget på den amerikanske indkøbsforening Express Scripts nationale tilskudsliste, der gælder for en lang række sygekasser i 2018.Det bekræfter Novo Nordisk over for Ritzau Finans.Optagelsen er et vigtigt skridt i Novos arbejde med at indgå kontrakter med de store indkøbsforeninger, der står for sygekassernes indkøb og også rådgiv..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Mærsk/Sydbank: Aktionærer kan se frem til udbetaling i 2018 eller 2019
2
Genmab/Sydbank: Stærk Darzalex-prognose bør sende aktien op
3
Aktier/åbning: Genmab brager frem og trækker eliteindekset i plus
4
Vestas vinder mølleordre i USA
5
Aktier/tendens: Genmab, ISS og William i fokus i rød handelsstart

Relaterede aktiekurser

Ericsson Telefonab L M s.. 54,28 -1,0% Fald i aktiekurs
AT&T Inc 36,31 0,0% Aktiekurs uændret
Sprint Corporation 5,40 0,0% Aktiekurs uændret
Apple Inc 171,07 0,0% Aktiekurs uændret
Ericsson - ADS each repr.. 6,66 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. februar 2018 13:36:30
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseBuild_20180222.1 - EUROWEB5 - 2018-02-22 13:36:30 - 2018-02-22 13:36:30 - 1 - Website: OKAY